Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesBlood pressure lowering efficacy of reserpine for primary hypertension
Cochrane Reviews, 10/09/09
Reserpine is effective in reducing SBP roughly to the same degree as other first–line antihypertensive drugs. However, the authors could not make definite conclusions regarding the dose–response pattern because of the small number of included trials. More RCTs are needed to assess the effects of reserpine on blood pressure and to determine the dose–related safety profile before the role of this drug in the treatment of primary hypertension can be established.
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 47%
Intradialytic Hypertension: A Less-Recognized Cardiovascular Complication of Hemodialysis
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 46%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 46%
Hypertension in Women: More Evidence for the Role of Lifestyle
Nursing for Women's Health, 10/12/09
Relevance Score: 46%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 46%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Non-adherence to statin therapy: a major challenge for preventive cardiology
Expert Opinion in Pharmacotherapy, 12/08/09
A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management
Pharmacoepidemiology and Drug Safety, 12/08/09
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/07/09
Sponsor
Article Search
Sponsor